Vivo Capital, LLC Aurinia Pharmaceuticals Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$17.78 - $33.08 $8.9 Million - $16.6 Million	-500,732 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $5.68 Million - $10.7 Million	500,732 New	500,732 $7.27 Million
Q3 2019 Nov 13, 2019	SELL	$5.34 - $6.59 $10.2 Million - $12.6 Million	-1,913,623 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.05 - $6.75 $4.24 Million - $4.73 Million	700,333 Added 57.72%	1,913,623 $12.6 Million
Q3 2017 Nov 13, 2017	BUY	$5.71 - $6.9 $6.93 Million - $8.37 Million	1,213,290	1,213,290 $7.61 Million

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.37B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.